Medical Devices

Europe Continuous Glucose Monitoring Systems Market by Component (Sensors, Transmitters & Receivers, and Integrated Insulin Pumps), Demographics (Child Population (≤14 years), and Adult Population (>14 years)), and End User (Diagnostic Centers/Clinics, ICUs, and Home Healthcare) - Global Opportunity Analysis and Industry Forecast, 2014-2022

  • ALL393746
  • 162 Pages
  • December 2016
  • Medical Devices

Continuous glucose monitoring (CGM) is a latest technological advancement in the field of diabetes management. CGM system is a type of device that monitors glucose by a biosensor, which is inserted through the transcutaneous or subcutaneous route. This embedded sensor measures glucose levels in interstitial fluid or blood, and transmits the information using a transmitter to a receiver/monitor to display the results. The use of CGM systems is crucial to avoid diabetic complications, as this technology can be used to periodically monitor the glucose levels. Therefore, glucose monitoring device manufacturing companies focus on the development of novel and technologically advanced CGMS. It offers a wide range of applications for all age cohorts, healthcare settings (diagnostic centers/clinics, hospital ICUs, and home healthcare), and geographies. Thus, CGMS market poses lucrative opportunities for both CGMS manufacturers and insulin pump manufacturers.

The European CGMS market generated $58 million in 2015, and is projected to reach $792 million by 2022, expanding at a CAGR of 44.9% during the forecast period. High-tech CGMS devices, such as wearable & smartphone-connected CGMS, non-invasive CGMS, smartphone-connected CGMS, and “smart” diabetes management solution (also called artificial/bionic pancreas), are expected to result in higher adoption of CGMS among endocrinologists and patients.

The market is categorized based on component, demographics, end user, and country. The component segment includes durable components such as transmitters & receivers and integrated insulin pumps; and disposable components such as sensors. Sensors occupy a dominant share in the European CGMS market owing to short life span of these devices, recurring sales of CGMS, and bulk purchases. Therefore, they are deployed in diagnostic centers/clinics. Moreover, the adoption of CGMS in hospital ICUs and in-home healthcare settings has increased in recent years. End users of CGMS devices are diabetic patients, categorized into child population (≤14 years) and adult population (>14 years).

The report includes comprehensive analysis and segmentation of different countries in Europe, including UK, France, Germany, Spain, Italy, the Netherlands, Norway, Sweden, Denmark, Finland, and rest of Europe.

Major strategies adopted by market players are collaborations, product launches, and product approvals. Agreement/partnership strategy by companies enables greater focus on innovation, distribution, and commercialization of devices. For instance, in 2016, Senseonics signed an agreement with Roche to commercialize Senseonics’ Eversense continuous glucose monitoring system. Under this agreement, Roche can sell its CGM systems in Germany, Italy, and the Netherlands

KEY MARKET BENEFITS:

  • In-depth and country-level analysis provides the current trends and future estimations in the European CGMS market from 2014 to 2022, which would enable stakeholders to capitalize on the prevailing market opportunities.
  • Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
  • In-depth analysis of current research and clinical developments within the European CGMS market is provided along with the key dynamic factors.
  • The key players in the European CGMS market are profiled, along with their development strategies, to understand the competitive outlook.

 KEY MARKET SEGMENTS:

By Component

  • Sensors
  • Transmitters & Receivers
  • Integrated Insulin Pumps

By Demographics

  • Child Population (≤14 years)
  • Adult Population (>14 years)

By End User

  • Diagnostics/Clinics
  • ICUs
  • Home Healthcare

By Country

  • UK
  • Germany
  • France
  • Spain
  • Italy
  • The Netherlands
  • Norway
  • Sweden
  • Denmark
  • Finland
  • Rest of Europe

The key players profiled in the report are listed below:

  • Abbott Laboratories
  • Dexcom, Inc.
  • Echo Therapeutics, Inc.
  • Johnson & Johnson
  • Medtronic plc
  • Senseonics Holdings, Inc.
  • F. Hoffmann-La Roche Ltd.

Other players in the European CGMS market include (profiles not included in the report):

  • AgaMatrix, Inc.
  • GlySure
  • OrSense
  • Ypsomed
Please Select Format

Enquiry About Report

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

World Anesthesia Monitoring Devices Market - Opportunities and Forecasts, 2014 - 2020

Anesthesia can be monitored depending on the types of cases performed for the purpose of continuous assessment of the patients by measuring parameters such as patients oxygenation, circulation, ventilation, and temperature. It is logical that other clinical observations be supplemented to different monitoring devices.

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

World Anti-Snoring Devices and Snoring Surgery Market - Opportunities and Forecasts, 2014 - 2020

The anti-snoring devices and snoring surgery market has gained traction in the recent years due to growing consciousness about the ill effects of snoring and sleep apnea, and these treatments ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

World Sports Medicine Market - Opportunities and Forecasts, 2014 - 2020

The sports medicine market consists of products used by athletes or sportspersons to prevent injuries and protect themselves including devices that boost performance. The product offerings play a crucial role in the rehabilitation, recovery, endurance, and monitoring of athletes in sports.

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

World 3D Printing Medical Devices Market - Opportunities and Forecasts, 2014 - 2020

Large patient population, expansion of distribution networks by the key market players, awareness about benefits of 3D printing technology and its adoption across the emerging countries in Asia-Pacific are the ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

World Veterinary Imaging Market - Opportunities and Forecasts, 2014 - 2020

Veterinary diagnostic imaging consists of a non-invasive method of obtaining images of the animal body for the purpose of medical diagnostics. The animals considered for imaging are small companion animals, ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

BRIC Diabetes Care Devices Market - Opportunities and Forecasts, 2014 - 2020

Diabetes care devices helps in the management of blood glucose levels caused in patients due to inadequate insulin production or insulin resistance. The Diabetes Care Devices Market in Brazil, Russia, ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

2017 © Copyright Big Market Research

View Pricing >>